Asset Details
Do you wish to reserve the book?
Adipose‐Derived Stem Cells Induce Angiogenesis via Microvesicle Transport of miRNA‐31
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Adipose‐Derived Stem Cells Induce Angiogenesis via Microvesicle Transport of miRNA‐31
Do you wish to request the book?
Adipose‐Derived Stem Cells Induce Angiogenesis via Microvesicle Transport of miRNA‐31
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Adipose‐Derived Stem Cells Induce Angiogenesis via Microvesicle Transport of miRNA‐31
2016
Overview
The potential effects of stem cell‐released microvesicles (MVs) in proangiogenic therapy were explored. MVs were released from adipose‐derived stem cells (ASCs) and were able to increase the migration and tube formation of human umbilical vein endothelial cells. MVs from ASCs, particularly from endothelial differentiation medium‐preconditioned ASCs, were found to have elevated levels of microRNA‐31 and to promote angiogenesis.
Cell secretion is an important mechanism for stem cell‐based therapeutic angiogenesis, along with cell differentiation to vascular endothelial cells or smooth muscle cells. Cell‐released microvesicles (MVs) have been recently implicated to play an essential role in intercellular communication. The purpose of this study was to explore the potential effects of stem cell‐released MVs in proangiogenic therapy. We observed for the first time that MVs were released from adipose‐derived stem cells (ASCs) and were able to increase the migration and tube formation of human umbilical vein endothelial cells (HUVECs). Endothelial differentiation medium (EDM) preconditioning of ASCs upregulated the release of MVs and enhanced the angiogenic effect of the released MVs in vitro. RNA analysis revealed that microRNA was enriched in ASC‐released MVs and that the level of microRNA‐31 (miR‐31) in MVs was notably elevated upon EDM‐preconditioning of MV‐donor ASCs. Further studies exhibited that miR‐31 in MVs contributed to the migration and tube formation of HUVECs, microvessel outgrowth of mouse aortic rings, and vascular formation of mouse Matrigel plugs. Moreover, factor‐inhibiting HIF‐1, an antiangiogenic gene, was identified as the target of miR‐31 in HUVECs. Our findings provide the first evidence that MVs from ASCs, particularly from EDM‐preconditioned ASCs, promote angiogenesis and the delivery of miR‐31 may contribute the proangiogenic effect.
Significance
This study provides the evidence that microvesicles (MVs) from adipose‐derived stem cells (ASCs), particularly from endothelial differentiation medium (EDM)‐preconditioned ASCs, promote angiogenesis. An underlying mechanism of the proangiogenesis may be the delivery of microRNA‐31 via MVs from ASCs to vascular endothelial cells in which factor‐inhibiting HIF‐1 is targeted and suppressed. The study findings reveal the role of MVs in mediating ASC‐induced angiogenesis and suggest a potential MV‐based angiogenic therapy for ischemic diseases.
Publisher
AlphaMed Press,Oxford University Press
Subject
/ Adult Stem Cells - physiology
/ Animals
/ Cell-Derived Microparticles - metabolism
/ Cell-Derived Microparticles - physiology
/ Human Umbilical Vein Endothelial Cells - physiology
/ Humans
/ Hypoxia-Inducible Factor 1, alpha Subunit - antagonists & inhibitors
/ Hypoxia-Inducible Factor 1, alpha Subunit - genetics
/ Male
/ Mice
/ miRNA
/ Neovascularization, Physiologic - genetics
/ Proteins
